Bremelanotide
Selective melanocortin receptor agonist for cutting-edge sexual health and pigmentation research. Cyclic heptapeptide structure ensures enhanced stability and receptor specificity.
Our Bremelanotide (PT141) API (CAS:189691-06-3) is a cyclic heptapeptide melanocortin receptor agonist, meeting international quality control requirements for scientific research and pharmaceutical R&D. With stable supply, global fast delivery and professional service, we help customers efficiently advance R&D and industrialization.
| CAS | 189691-06-3 |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Molecular Weight | 1025.16 g/mol |
| Category | Melanocortin & Skin Pigment Peptides |
| Purity | >=99% (HPLC) |
| Status | Research-grade, analytical verified |
| Applications | Sexual dysfunction research, melanocortin signaling, pigmentation studies |
| CAS | 189691-06-3 |
|---|---|
| Applications |
Related products
-
SS-31 (Elamipretide)
CAS: 736992-21-5 -
Selank
CAS: 129954-34-3Applications: Anxiety research, Immunomodulation, Stress modulation -
Semax
CAS: 80714-61-0Applications: BDNF modulation, Cognitive research, Neuroprotection studies, Stroke recovery -
Thymulin
CAS: 63958-90-7Applications: Cancer Immunotherapy, Immunosenescence & Aging, Vaccine Adjuvant Research